Associate Professor, Internal Medicine, Ohio State University College of Medicine
Cardiology
Dr. Raymond D. Magorien, MD
|
|
Give Review
Raymond Magorien works in the field of Cardiology. He researched medicine at The Ohio State University College of Medicine. He received awards:"CMS Meaningful Use Stage 1 Certification" and "Fellow (FACC)". Raymond Magorien has written publications. He has 74 publications published with PubMed. The lastest publication is: 'Poloxamer-188 as an adjunct to primary percutaneous transluminal coronary angioplasty for acute myocardial infarction.' He is registered with Medicare and accepts Medicare payments.
Publications
- Comparison of Impella and intra-aortic balloon pump in high-risk percutaneous Coronary intervention: Vascular complications and incidence of bleeding.
- Effect of platelet antigen polymorphism on platelet inhibition by aspirin, clopidogrel, or their combination.
- Advancing immunosuppression therapy to counter the progression of cardiac allograft vasculopathy.
- Rotational X-ray Coronary angiography.
- Development of pharmacodynamic tolerance to prozosin in congestive Heart failure.
- InterAtrial conduction (activation) times.
- Electrophysiologic studies of perphenazine and protriptyline in a patient with psychotropic drug-induced ventricular Fibrillation.
- Fluoroscopic diagnosis of native valve endocarditis.
- American College of Cardiology training statement on recommendations for the structure of an optimal adult interventional cardiology training program: a report of the ...
- Poloxamer-188 as an adjunct to primary percutaneous transluminal Coronary angioplasty for acute myocardial infarction.
- Myocardial infarct Artery patency and reocclusion rates after treatment with duteplase at the dose used in the International Study of Infarct Survival-3. Burroughs Wel...
- Cardiac catheterization and Coronary angiography using 5 French preformed (Judkins) catheters from the percutaneous right brachial approach: a comparative analysis wit...
- Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for Acute myocardial infarction: results of...
- Positive inotropic effects of hydralazine in human subjects: comparison with prazosin in the setting of congestive Heart failure.
- Improvement of human Myocardial mitochondria after dobutamine: a quantitative ultrastructural study.
- Hydralazine and isosorbide dinitrate: comparative central and regional hemodynamic effects when administered alone or in combination.
- Drug regimens for congestive Heart failure.
- Autonomic tone of patients during an electrophysiological catheterization. The role of autonomic influences on the reproducibility of sinus node function studies.
- Biochemical and histologic correlates of ventricular end-diastolic pressure.
- Human Myocardial morphologic and functional changes in the first 24 hours after doxorubicin administration.
- Human Myocardial mitochondria: size differences in parts of the cell.
- Prazosin and hydralazine in congestive Heart failure. Regional hemodynamic effects in relation to dose.
- Long-term survival following cardiac rupture with subsequent development of left ventricular pseudoaneurysm.
- Vasodilators and prostaglandin inhibitors in primary pulmonary Hypertension.
- Hemodynamic effects of vasodilator therapy in severe left heart failure combined with large Atrial septal defects.
- The effect of vasodilator therapy on systolic and diastolic time intervals in congestive Heart failure.
- Effects of hydralazine on Coronary blood flow and myocardial energetics in congestive heart failure.
- Canine cobalt Cardiomyopathy: a model for the study of heart failure.
- The hemodynamic and metabolic advantages gained by a three-day infusion of dobutamine in patients with congestive Cardiomyopathy.
- Early changes in human Myocardial nuclei after doxorubicin.
- Heart rate responsiveness after sustained chronotropic stimulation with a beta 1-adrenergic receptor agonist.
- Clonidine in congestive Heart failure: a vasodilator with negative inotropic effects.
- Dobutamine and hydralazine: comparative influences of positive inotropy and vasodilation on Coronary blood flow and myocardial energetics in nonischemic congestive hea...
- Assessment of left ventricular pressure-volume relations using gated radionuclide angiography, echocardiography, and micromanometer pressure recordings. A new method f...
- Long-term benefit of dobutamine in patients with congestive Cardiomyopathy.
- Reproducibility of echocardiography in chronic congestive Heart failure.
- Doxorubicin cardiotoxicity.
- Factors influencing the one-year mortality of dilated Cardiomyopathy.
- Amrinone in severe congestive Heart failure: another look at an intriguing new cardioactive drug.
- Amrinone therapy for congestive heart failure in outpatients with idiopathic dilated Cardiomyopathy.
- Regression of myocardial cellular hypertrophy with vasodilator therapy in chronic congestive heart failure associated with idiopathic dilated Cardiomyopathy.
- Acute and chronic isosorbide dinitrate therapy in congestive Heart failure: demonstration of improved exercise capacity and differing arterial and venous tolerance dur...
- Acute massive (pericardial effusive) pulmonary thromboembolism--pulmonary embolectomy revisited.
- Human myocardial histologic characteristics in congestive Heart failure.
- Differentiating characteristics of myocardial nuclei in Cardiomyopathy.
- Reperfusion of the human myocardium by saphenous vein bypass grafts. Biochemical considerations.
- Attempt to prevent doxorubicin-induced Acute human myocardial morphologic damage with acetylcysteine.
- Nifedipine in congestive Heart failure: effects on resting and exercise hemodynamics and regional blood flow.
- Beneficial effects of nifedipine on rest and exercise myocardial energetics in patients with congestive Heart failure.
- The effect of age on central and regional hemodynamics.
- Combined systolic time intervals and M-mode echocardiography in the evaluation of central hemodynamics in primary pulmonary Hypertension.
- Hydralazine therapy in chronic congestive Heart failure. Sustained central and regional hemodynamic responses.
- Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive Heart failure.
- Captopril in primary pulmonary Hypertension.
- Hemodynamic correlates for timing intervals, ejection rate and filling rate derived from the radionuclide angiographic volume curve.
- The effect of first-dose doxorubicin on the cyclic nucleotide levels of the human myocardium.
- Biochemical measurements of endoMyocardial biopsies.
- The role of subendocardial ischemia in perpetuating myocardial failure in patients with nonischemic congestive Cardiomyopathy.
- The anatomic relationship of the esophageal lead to the left atrium.
- N-acetylcysteine prevents the doxorubicin-induced decrease of cyclic GMP.
- Effect of vasoactive intestinal polypeptide on the canine cardiovascular system.
- Postural influences on the hemodynamic responses to vasodilating drugs in congestive Heart failure.
- Influence of exercise on Coronary sinus blood flow determinations.
- Human and canine ventricular vasoactive intestinal polypeptide: decrease with Heart failure.
- Aging of the human myocardium: a histologic study based upon endoMyocardial biopsy.
- Failure of percutaneous transluminal Coronary angioplasty to stimulate platelet and prostaglandin activity.
- Regional hemodynamic effects of clonidine in congestive Heart failure.
- Rest and exercise cardiovascular effects of terazosin in congestive Heart failure.
- Evaluation of a prolonged infusion of recombinant tissue-type plasminogen activator (Duteplase) in preventing reocclusion following successful thrombolysis in Acute my...
- Emergency-department diagnosis of Acute myocardial infarction and ischemia: a cost analysis of two diagnostic protocols.
- Statin therapy, LDL cholesterol, C-reactive protein, and coronary Artery disease.
- Clinical and angiographic outcomes after treatment of de novo Coronary stenoses with a novel platinum chromium thin-strut stent: primary results of the PERSEUS (Prospe...
- Drug eluting stent implantation for the treatment of symptomatic Myocardial bridging is associated with favorable peri-procedural results and short-term outcomes.
Schools
Ohio State University College Of Medicine and Public Health
Oh State University Hospital
Procedures Preformed
- Cardiac Catheterization (incl. Coronary Angiography)
- Removal or Revision of Pacemaker or Cardioverter and-or Defibrillator
- Transcatheter Aortic Valve Replacement (TAVR)
Conditions Treated
- Arrhythmias (incl. Atrial Fibrillation)
- Cardiomegaly
- Cardiomyopathy
- Carotid Artery Disease
- View All
Doctors Specialties
- Cardiology
- Interventional Cardiology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACC)
Education
-
Ohio State University Hospital -
The Ohio State University College of Medicine
Hospital
-
Ohio State University Wexner Medical Center
Drug Facts
| NPI NUMBER | 1558375188 | |
| NPPES Provider LastName | MAGORIEN | |
| NPPES Provider FirstName | RAYMOND | |
| NPPES Provider ZIPCode | 432101240 | |
| NPPES Provider State | OH | |
| Specialty Description | Cardiology | |
| Total Claim Count | 2307.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1558375188 |
| Last Name Of The Provider | MAGORIEN |
| First Name Of The Provider | RAYMOND |
| View All |
Similar Doctors
|
Dr. Arnold P. Good, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Steven J. Yakubov, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Aref M. Abou-Amro, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. David R. Richards, DO
This Doctor is OpenDoctor Recommended.
|
|
Dr. Timothy L. Timko, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Alex J. Auseon, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sreedhar R. Billakanty, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles J. Hardebeck, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nagesh Chopra, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. David A. Orsinelli, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Teresa L. Caulin-Glaser, MD |